72 related articles for article (PubMed ID: 16762494)
1. Aurora kinases A and B and familial breast cancer risk.
Tchatchou S; Wirtenberger M; Hemminki K; Sutter C; Meindl A; Wappenschmidt B; Kiechle M; Bugert P; Schmutzler RK; Bartram CR; Burwinkel B
Cancer Lett; 2007 Mar; 247(2):266-72. PubMed ID: 16762494
[TBL] [Abstract][Full Text] [Related]
2. Functional Phe31Ile polymorphism in Aurora A and risk of breast carcinoma.
Sun T; Miao X; Wang J; Tan W; Zhou Y; Yu C; Lin D
Carcinogenesis; 2004 Nov; 25(11):2225-30. PubMed ID: 15271856
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms of the AURKA (STK15/Aurora Kinase) Gene and Breast Cancer Risk (United States).
Cox DG; Hankinson SE; Hunter DJ
Cancer Causes Control; 2006 Feb; 17(1):81-3. PubMed ID: 16411056
[TBL] [Abstract][Full Text] [Related]
4. Functional polymorphism 57Val>Ile of aurora kinase A associated with increased risk of gastric cancer progression.
Ju H; Cho H; Kim YS; Kim WH; Ihm C; Noh SM; Kim JB; Hahn DS; Choi BY; Kang C
Cancer Lett; 2006 Oct; 242(2):273-9. PubMed ID: 16412566
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A gene is frequently amplified in basal-like breast cancer.
Staff S; Isola J; Jumppanen M; Tanner M
Oncol Rep; 2010 Feb; 23(2):307-12. PubMed ID: 20043089
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer risk associated with genotypic polymorphism of the mitosis-regulating gene Aurora-A/STK15/BTAK.
Lo YL; Yu JC; Chen ST; Yang HC; Fann CS; Mau YC; Shen CY
Int J Cancer; 2005 Jun; 115(2):276-83. PubMed ID: 15688402
[TBL] [Abstract][Full Text] [Related]
7. Common genetic polymorphisms of AURKA and prostate cancer risk.
Feik E; Baierl A; Madersbacher S; Schatzl G; Maj-Hes A; Berges R; Micksche M; Gsur A
Cancer Causes Control; 2009 Mar; 20(2):147-52. PubMed ID: 18802780
[TBL] [Abstract][Full Text] [Related]
8. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetic profiling of Aurora kinase B is associated with overall survival in metastatic colorectal cancer.
Pohl A; Azuma M; Zhang W; Yang D; Ning Y; Winder T; Danenberg K; Lenz HJ
Pharmacogenomics J; 2011 Apr; 11(2):93-9. PubMed ID: 20368716
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in nonhomologous end-joining genes associated with breast cancer risk and chromosomal radiosensitivity.
Willems P; Claes K; Baeyens A; Vandersickel V; Werbrouck J; De Ruyck K; Poppe B; Van den Broecke R; Makar A; Marras E; Perletti G; Thierens H; Vral A
Genes Chromosomes Cancer; 2008 Feb; 47(2):137-48. PubMed ID: 18000863
[TBL] [Abstract][Full Text] [Related]
12. The functional genetic variant Ile646Val located in the kinase binding domain of the A-kinase anchoring protein 10 is associated with familial breast cancer.
Wirtenberger M; Schmutzhard J; Hemminki K; Meindl A; Sutter C; Schmutzler RK; Wappenschmidt B; Kiechle M; Arnold N; Weber BH; Niederacher D; Bartram CR; Burwinkel B
Carcinogenesis; 2007 Feb; 28(2):423-6. PubMed ID: 16956908
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.
Zhang Y; Newcomb PA; Egan KM; Titus-Ernstoff L; Chanock S; Welch R; Brinton LA; Lissowska J; Bardin-Mikolajczak A; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):353-8. PubMed ID: 16492928
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H
Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923
[TBL] [Abstract][Full Text] [Related]
16. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
Naidu R; Har YC; Taib NA
J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
[TBL] [Abstract][Full Text] [Related]
17. Breast cancer risk associated with AURKA 91T -->A polymorphism in relation to BRCA mutations.
Vidarsdottir L; Bodvarsdottir SK; Hilmarsdottir H; Tryggvadottir L; Eyfjord JE
Cancer Lett; 2007 Jun; 250(2):206-12. PubMed ID: 17113223
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Breast Cancer Res Treat; 2010 Apr; 120(3):727-36. PubMed ID: 19672706
[TBL] [Abstract][Full Text] [Related]
19. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
Gao LB; Bai P; Pan XM; Jia J; Li LJ; Liang WB; Tang M; Zhang LS; Wei YG; Zhang L
Breast Cancer Res Treat; 2011 Jan; 125(2):571-4. PubMed ID: 20640596
[TBL] [Abstract][Full Text] [Related]
20. AURKA and breast cancer in BRCA1/2 mutation carriers.
Bodvarsdottir SK; Vidarsdottir L; Eyfjord JE
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2517. PubMed ID: 18006949
[No Abstract] [Full Text] [Related]
[Next] [New Search]
